(Q39902951)

15 September 2017

title

Effects of Darbepoetin Alfa with exercise in cancer patients undergoing chemotherapy: an explorative study (English)

1 reference

15 September 2017

0 references

1 reference

M Rørth

1

1 reference

15 September 2017

K R Madsen

2

1 reference

15 September 2017

S H Burmølle

3

1 reference

15 September 2017

J Midtgaard

4

1 reference

15 September 2017

C Andersen

5

1 reference

15 September 2017

B Nielsen

6

1 reference

15 September 2017

M Stage

7

1 reference

15 September 2017

L Adamsen

8

1 reference

15 September 2017

publication date

31 January 2010

1 reference

Scandinavian Journal of Medicine and Science in Sports

15 September 2017

published in

1 reference

15 September 2017

volume

21

1 reference

15 September 2017

issue

3

1 reference

15 September 2017

page(s)

369-377

1 reference

The effect of a multidimensional exercise intervention on physical capacity, well-being and quality of life in cancer patients undergoing chemotherapy.

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01066.X

Effects of exercise in combination with epoetin alfa during high-dose chemotherapy and autologous peripheral blood stem cell transplantation for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01066.X

Review of exercise intervention studies in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01066.X

Does recombinant human Epo increase exercise capacity by means other than augmenting oxygen transport?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01066.X

New avenues of exploration for erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01066.X

Differential effects of erythropoietin on neural and cognitive measures of executive function 3 and 7 days post-administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01066.X

Erythropoietin improves mood and modulates the cognitive and neural processing of emotion 3 days post administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01066.X

Evidence-based treatment for cancer-related fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01066.X

Fatigue mediates the effects of exercise on quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01066.X

Weekly epoetin beta maintains haemoglobin levels and improves quality of life in patients with non-myeloid malignancies receiving chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0838.2009.01066.X

10.1111/J.1600-0838.2009.01066.X

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference